Novel Therapies in Takayasu Arteritis.

Front Med (Lausanne) · 2021 · PMC8790042 · PMID 35096902

Europe PMC DOI

hedged sentence

0.0596

closest p · 1.2× alpha

0.0596

boldest claim

The sentences

did not reach statistical significancep = 0.0596so close (0.05 < p ≤ 0.1)

In fact, after 1 year of follow-up, relapse-free survival tended to be improved in patients treated with tocilizumab, but the results did not reach statistical significance [HR 0.41 (95.41% CI 0.15 to 1.10; p = 0.0596)] ( 31 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.